Ian Faragher

Going loopy: using ScopeGuide to demonstrate incarceration of a colonoscope within an inguinal hernia

Nicole L Tham, Michael Kok-Yee Hong, Kumanan Nalankilli, Alan Moss, Ian G Faragher

Journal article  |  2020  |  ANZ Journal of Surgery

Patterns of surveillance for colorectal cancer: Experience from a single large tertiary institution

Samantha A Pellegrino, Steven Chan, Koen Simons, Rita Kinsella, Peter Gibbs, Ian G Faragher, Irene Deftereos, Justin Mc Yeung

Journal article  |  2020  |  Asia-Pacific Journal of Clinical Oncology

AIM: Colorectal cancer surveillance is an essential part of care and should include clinical review and follow-up investigations. ..

Real world outcomes for neoadjuvant capecitabine versus infusional 5-fluorouracil in the treatment of locally advanced rectal cancer.

Matthew Loft, Hui-Li Wong, Suzanne Kosmider, Margaret Lee, Jeanne Tie, Rachel Wong, Ian T Jones, Matthew Croxford, Malcolm Steel, Ian Faragher, Mario Guerrieri, Michael Christie, Peter Gibbs

Journal article  |  2020  |  Internal Medicine Journal

BACKGROUND: Neoadjuvant chemoradiation therapy (CRT) is standard of care treatment for locally advanced rectal cancer (LARC). A pa..

Overexpression of TP53 protein is associated with the lack of adjuvant chemotherapy benefit in patients with stage III colorectal cancer

David S Williams, Dmitri Mouradov, Clare Browne, Michelle Palmieri, Meg J Elliott, Rebecca Nightingale, Catherine G Fang, Rita Li, John M Mariadason, Ian Faragher, Ian T Jones, Leonid Churilov, Niall C Tebbutt, Peter Gibbs, Oliver M Sieber

Journal article  |  2020  |  Modern Pathology

TP53 mutations drive colorectal cancer development, with missense mutations frequently leading to accumulation of abnormal TP53 pr..

State-wide outcomes in elective rectal cancer resection: is there a case for centralization in Victoria?

Michael K-Y Hong, Justin MC Yeung, David AK Watters, Ian G Faragher

Journal article  |  2019  |  ANZ Journal of Surgery

BACKGROUND: The role of service centralization in rectal cancer surgery is controversial. Recent studies suggest centralization to..

Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer

Jeanne Tie, Joshua D Cohen, Yuxuan Wang, Michael Christie, Koen Simons, Margaret Lee, Rachel Wong, Suzanne Kosmider, Sumitra Ananda, Joseph McKendrick, Belinda Lee, Jin Hee Cho, Ian Faragher, Ian T Jones, Janine Ptak, Mary J Schaeffer, Natalie Silliman, Lisa Dobbyn, Lu Li, Cristian Tomasetti, et al.

Journal article  |  2019  |  JAMA Oncology

Importance: Adjuvant chemotherapy in patients with stage III colon cancer prevents recurrence by eradicating minimal residual dise..

Treatment of colonoscopic perforation: outcomes from a major single tertiary institution

Carolyn R Chew, Justin MC Yeung, Ian G Faragher

Journal article  |  2019  |  ANZ Journal of Surgery

Understanding patient-reported outcome measures in colorectal cancer

Alex Besson, Irene Deftereos, Steven Chan, Ian G Faragher, Rita Kinsella, Justin MC Yeung

Journal article  |  2019  |  Future Oncology

Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study

Jeanne Tie, Joshua D Cohen, Yuxuan Wang, Lu Li, Michael Christie, Koen Simons, Hany Elsaleh, Suzanne Kosmider, Rachel Wong, Desmond Yip, Margaret Lee, Tran Ben, David Rangiah, Matthew Burge, David Goldstein, Madhu Singh, Iain Skinner, Ian Faragher, Matthew Croxford, Carolyn Bampton, et al.

Journal article  |  2019  |  Gut

Lymphocytic response to tumour and deficient DNA mismatch repair identify subtypes of stage II/III colorectal cancer associated with patient outcomes

David S Williams, Dmitri Mouradov, Robert N Jorissen, Marsali R Newman, Elham Amini, David K Nickless, Julie A Teague, Catherine G Fang, Michelle Palmieri, Marie J Parsons, Anuratha Sakthianandeswaren, Shan Li, Robyn L Ward, Nicholas J Hawkins, Ian Faragher, Ian T Jones, Peter Gibbs, Oliver M Sieber

Journal article  |  2019  |  Gut